163 related articles for article (PubMed ID: 2503226)
1. Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.
Bristow LJ; Bennett GW
Br J Pharmacol; 1989 Jul; 97(3):745-52. PubMed ID: 2503226
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
3. Changes in the behavioural response to a TRH analogue following chronic amitriptyline treatment and repeated electroconvulsive shock in the rat.
Bennett GW; Green AR; Lighton C; Marsden CA
Br J Pharmacol; 1986 May; 88(1):129-39. PubMed ID: 3085759
[TBL] [Abstract][Full Text] [Related]
4. The TRH analogue CG3509 increases in vivo catechol/ascorbate oxidation in the N. accumbens but not in the striatum of the rat.
Sharp T; Brazell MP; Bennett GW; Marsden CA
Neuropharmacology; 1984 Jun; 23(6):617-23. PubMed ID: 6431310
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of central and peripheral injection of various analogues and metabolites of thyrotropin releasing hormone (TRH).
Heal DJ; Sabbagh A; Youdim MB; Green AR
Neuropharmacology; 1981 Oct; 20(10):947-57. PubMed ID: 6795523
[No Abstract] [Full Text] [Related]
6. Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat; a role for central histamine receptors.
Bristow LJ; Bennett GW
Br J Pharmacol; 1988 Dec; 95(4):1292-302. PubMed ID: 3219488
[TBL] [Abstract][Full Text] [Related]
7. Comparative behavioural and biochemical effects of repeated intrathecal administration of thyrotrophin-releasing hormone (TRH) or two analogues of TRH in adult rats.
Fone KC; Johnson JV; Marsden CA; Bennett GW
Neuropharmacology; 1989 Aug; 28(8):867-75. PubMed ID: 2476681
[TBL] [Abstract][Full Text] [Related]
8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
[TBL] [Abstract][Full Text] [Related]
10. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
[TBL] [Abstract][Full Text] [Related]
11. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
Webster VA; Griffiths EC; Slater P
Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
[TBL] [Abstract][Full Text] [Related]
12. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues.
Heal DJ; Stoodley N; Elliott JM; Marsden CA; Bennett GW; Youdim MB
Neuropharmacology; 1987 Apr; 26(4):313-22. PubMed ID: 2884590
[TBL] [Abstract][Full Text] [Related]
13. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
15. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat.
Sharp T; Tulloch IF; Bennett GW; Marsden CA; Metcalf G; Dettmar PW
Neuropharmacology; 1984 Mar; 23(3):339-48. PubMed ID: 6145113
[TBL] [Abstract][Full Text] [Related]
16. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
[TBL] [Abstract][Full Text] [Related]
18. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of intrathecal galanin on behavioural and biochemical markers of spinal motor function in adult rats.
Fone KC; Dixon DM
Brain Res; 1991 Mar; 544(1):118-25. PubMed ID: 1713112
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated cocaine administration on the thyrotropin-releasing hormone level and receptors in the rat brain.
Jaworska-Feil L; Budziszewska B; LasoĊ W
Neuropeptides; 1997 Jun; 31(3):253-8. PubMed ID: 9243522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
